HealthBioAI

HealthBioAI Identifies Commonalities in Chronic Inflammatory Diseases Using Machine Learning and AI-Based Precision Diagnostics. The company initially focuses on precision immune modulation for neglected diseases, including Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME-CFS), and Chronic Lyme Disease. It aims to improve diagnostics, advance new science, and innovate therapies for these historically under-characterized conditions.